A detailed history of Paloma Partners Management CO transactions in Biogen Inc. stock. As of the latest transaction made, Paloma Partners Management CO holds 1,824 shares of BIIB stock, worth $271,812. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,824
Holding current value
$271,812
% of portfolio
0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$189.07 - $236.8 $344,863 - $431,923
1,824 New
1,824 $353,000
Q1 2024

May 15, 2024

BUY
$212.02 - $267.71 $35,407 - $44,707
167 Added 315.09%
220 $47,000
Q4 2023

Feb 14, 2024

BUY
$222.59 - $267.94 $11,797 - $14,200
53 New
53 $13,000
Q4 2022

Feb 14, 2023

BUY
$252.44 - $306.72 $254,207 - $308,867
1,007 New
1,007 $278,000
Q2 2022

Aug 15, 2022

BUY
$187.54 - $223.02 $120,775 - $143,624
644 Added 58.23%
1,750 $357,000
Q1 2022

May 16, 2022

SELL
$193.77 - $244.14 $61,037 - $76,904
-315 Reduced 22.17%
1,106 $233,000
Q4 2021

Feb 14, 2022

SELL
$223.92 - $287.77 $1.4 Million - $1.8 Million
-6,242 Reduced 81.46%
1,421 $341,000
Q3 2021

Nov 15, 2021

BUY
$282.99 - $369.05 $2.17 Million - $2.83 Million
7,663 New
7,663 $2.17 Million
Q2 2021

Aug 16, 2021

SELL
$259.0 - $414.71 $473,970 - $758,919
-1,830 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$242.95 - $284.63 $444,598 - $520,872
1,830 New
1,830 $512,000
Q4 2020

Feb 16, 2021

SELL
$236.26 - $355.63 $7.8 Million - $11.7 Million
-33,018 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$264.77 - $305.71 $986,003 - $1.14 Million
3,724 Added 12.71%
33,018 $9.37 Million
Q2 2020

Aug 14, 2020

BUY
$258.66 - $342.55 $6.95 Million - $9.21 Million
26,888 Added 1117.54%
29,294 $7.84 Million
Q1 2020

May 15, 2020

SELL
$268.85 - $341.04 $7.22 Million - $9.15 Million
-26,839 Reduced 91.77%
2,406 $762,000
Q4 2019

Feb 14, 2020

SELL
$220.06 - $304.07 $17.6 Million - $24.3 Million
-79,766 Reduced 73.17%
29,245 $8.68 Million
Q3 2019

Nov 14, 2019

BUY
$217.44 - $243.88 $12.6 Million - $14.1 Million
57,803 Added 112.88%
109,011 $25.4 Million
Q2 2019

Aug 14, 2019

BUY
$219.29 - $241.72 $3.53 Million - $3.9 Million
16,120 Added 45.94%
51,208 $12 Million
Q1 2019

May 15, 2019

BUY
$216.71 - $338.96 $7.38 Million - $11.5 Million
34,043 Added 3257.7%
35,088 $8.29 Million
Q4 2018

Feb 14, 2019

SELL
$278.5 - $352.75 $30.5 Million - $38.6 Million
-109,441 Reduced 99.05%
1,045 $314,000
Q3 2018

Nov 14, 2018

BUY
$293.51 - $383.83 $29.3 Million - $38.4 Million
99,969 Added 950.55%
110,486 $39 Million
Q2 2018

Aug 14, 2018

SELL
$257.52 - $306.91 $788,526 - $939,758
-3,062 Reduced 22.55%
10,517 $3.05 Million
Q1 2018

May 15, 2018

BUY
$260.13 - $367.91 $2.76 Million - $3.91 Million
10,621 Added 359.06%
13,579 $3.72 Million
Q4 2017

Feb 14, 2018

SELL
$307.64 - $344.58 $2.91 Million - $3.25 Million
-9,444 Reduced 76.15%
2,958 $942,000
Q3 2017

Nov 14, 2017

BUY
$281.15 - $329.69 $3.49 Million - $4.09 Million
12,402
12,402 $3.88 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.